CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 5 | 2011 | 553 | 602 | 91.9% | |
| CKD 5 | 2012 | 620 | 680 | 91.2% | |
| CKD 5 | 2013 | 633 | 695 | 91.1% | |
| CKD003 | 2014 | 649 | 705 | 92.1% | |
| CKD003 | 2015 | 629 | 687 | 91.6% | |
| NM84 | 2016 | 609 | 781 | 78.0% | |
| NM84 | 2018 | 543 | 736 | 73.8% | |
| NM84 | 2022 | 470 | 694 | 67.7% |
